The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease

NCT02422368 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Do not access to the drug

Conditions

Thyroid Eye Disease

Interventions

DRUG: Methylprednisolone + ASTED
DRUG: Methylprednisolone +Placebo

Sponsor

Iran University of Medical Sciences